Ledger.Open graph →
SEC Form D · Amendment · filed August 21, 2023

Cellebration Life Sciences, Inc

Offering
$20.0M
Sold
$2.8M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
PHOENIX, AZ
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (12)

Deven Patel · San Diego, CADirectorTim Kopatich · Phoenix, AZExecAnand Srivastava · San Diego, CADirectorBill Deegan · Phoenix, AZDirectorAnna-Lena Kamenetzky · San Francisco, CADirectorDana Stalder · San Francisco, CAExecZubin Bhettay · San Francisco, CADirectorMatthew Killebrew · Dallas, TXDirectorHallbjorn Karlsson · New York, NYExecGregg Rubin · New York, NYDirectorGrace Ray · New York, NYDirectorAnthony Sciortino · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗